|L - Antineoplastic and Immunomodulating Agents|
This group comprises preparations used in the treatment of malignant neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.
|L01 - Antineoplastic Agents|
Combination products are classified in L01XY - Combinations of antineoplastic agents.
Detoxifying agents used in connection with high dose treatment of antineoplastic agents are classified in V03AF (e.g. calcium folinate).
Radium-223 dichloride used in the treatment of cancer is classified in V10XX.
No DDDs have been established because of highly individualised use and wide dosage ranges. The doses used vary substantially because of various types and severity of neoplastic diseases, and also because of the extensive use of combination therapy.
The consumption of the antineoplastic agents is in some countries measured in grams. This is recommended as a method to be used internationally for these particular agents.
|L01X - Other Antineoplastic Agents|
This group comprises antineoplastic preparations which cannot be classified in the preceding groups.
|L01XX - Other Antineoplastic Agents|
Also antineoplastic agents for dermatological use are classified here.
All asparaginases regardless of origins are classified in L01XX02.
The 50-serie codes are used for single substances due to lack of numbers.